Celltrion
068270.KS
#789
Rank
โ‚น2.809 T
Marketcap
โ‚น12,840
Share price
-1.44%
Change (1 day)
21.66%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): โ‚น165.10

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น174.84. In 2024 the company made an earnings per share (EPS) of โ‚น123.90 a decrease over its 2023 EPS that were of โ‚น245.69.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น165.1033.26%
2024โ‚น123.90-49.57%
2023โ‚น245.69-2.08%
2022โ‚น250.90-11.72%
2021โ‚น284.212.03%
2020โ‚น278.5482.8%
2019โ‚น152.3718.31%
2018โ‚น128.79-36.33%
2017โ‚น202.29161.25%
2016โ‚น77.432.86%
2015โ‚น75.2817.84%
2014โ‚น63.885.87%
2013โ‚น60.34-70.85%
2012โ‚น207.00134.09%
2011โ‚น88.4343.59%
2010โ‚น61.5874.49%
2009โ‚น35.29317.8%
2008โ‚น8.45-71.7%
2007โ‚น29.85